2024 Q3 Report: Global Trends in Biopharma Transactions Each quarter, Locust Walk’s deal team compiles key statistics and trends on […]
CATEGORIES News Events Publications ARCHIVE Biotalk Episode 18: A Conversation with Lindsay Rosenwald of Fortress Biotech Podcast: Play in new window | Download (Duration:
CATEGORIES News Events Publications ARCHIVE Biotalk Episode 17: Q2 2024 Report: Global Trends in Biopharma Transactions Podcast: Play in new window | Download (Duration:
2024 Q2 Report: Global Trends in Biopharma Transactions Each quarter, Locust Walk’s deal team compiles key statistics and trends on
LOCUST WALK NEWS CytoReason secures $80M from OurCrowd, NVIDIA, Pfizer, and Thermo Fisher Scientific to scale its AI disease models
LOCUST WALK NEWS Locust Walk Acquisition Corp. Announces Pricing of Upsized $153,000,000 Initial Public Offering PHILADELPHIA and BOSTON, Jan. 7,
LOCUST WALK NEWS Ascentage Pharma Signs Option Agreement with Takeda to Enter into Exclusive Global License for Olverembatinib Ascentage Pharma
Align Summit 2024 Align Summit – April 25, 2024 Locust Walk proudly partnered with MassBio and McKinsey & Co. for
Loucst Walk RNA Innovation Conference in partnership with Dr. Frank Slack, Director of the Harvard Medical School Initiative for RNA
CATEGORIES News Events Publications ARCHIVE Biotalk Episode 16: A Conversation with Stephen Sands of Lazard Podcast: Play in new window | Download (Duration: 33:54